Lv62
2460 积分 2022-07-20 加入
Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate
29天前
已完结
Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer’s Disease
1个月前
已完结
Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults
1个月前
已完结
Neonatal Fc Receptor Inhibitor Therapeutics in Neuromuscular Disease
1个月前
已完结
Efficacy and safety of efgartigimod in patients with neurological autoimmune diseases
1个月前
已完结
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
1个月前
已完结
Respiratory syncytial virus infection in adults
3个月前
已完结
Respiratory Syncytial Virus Infection in Adults
3个月前
已完结
Forecasting cardiovascular disease risk and burden in China from 2020 to 2030: a simulation study based on a nationwide cohort
4个月前
已完结
T cell dynamics with neoadjuvant immunotherapy in head and neck cancer
6个月前
已完结
皖公网安备34019202002308
